Evidence map›Paper›PMID 40330492›Full record

ArticlePharmacogenomics and personalized medicine2025

Prevalence of

Xiu-Ping Li, Jun-Ling Wang, San-Xi Lei, Bo-Yu Chen, Xiang Ma, Fei He, Chao-Fu Yue, Hong-Xia Liu, Jian-Peng Hu, Qian Xiong and 4 more

Abstract read
In one paragraph

Article in Pharmacogenomics and personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Major Allele Frequencies inJournal of personalized medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiu-Ping Li *Department of Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.ORCID 0000-0002-7306-545X
Jun-Ling Wang *Department of Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
San-Xi LeiDepartment of Cerebrovascular, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Bo-Yu ChenDepartment of Cerebrovascular, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Xiang MaDepartment of Cerebrovascular, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Fei HeDepartment of Orthopedics, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Chao-Fu YueDepartment of Intensive Care, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Hong-Xia LiuDepartment of Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Jian-Peng HuDepartment of Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Qian XiongDepartment of Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Ting JiDepartment of Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Zheng-Fu ZhangCollege of Agriculture and Biological Science, Dali University, Dali, People's Republic of China.
Yong SunDepartment of Cardiovascular, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.
Hong-Wei LiDepartment of Clinical Laboratory, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan Province, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: The CYP2C19 enzyme is essential for activation of the antiplatelet drug clopidogrel. Genetic variations in CYP2C19 are known to influence individual drug responses. Here, differences in Methods: The Results: The proportions of the Conclusion: These results represent the first comprehensive profile of

Indexed as

alleleclopidogrelCYP2C19genotypephenotypeplateau

Identifiers

PMID40330492
PMCPMC12054638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.